NVX-207 Inhibitor

Name: NVX-207 Inhibitor; MyBioSource
Brand: MyBioSource
SKU: MBS5755295
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5755295

MBS5755295 is an inhibitor targeting NVX-207. NVX-207 is a derivative of betulinic acid. It has anti-cancer activity. More details

Please Inquire

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

NVX-207, Inhibitor

Full Product Name

NVX-207

Product Gene Name

NVX-207, inhibitor

Form/Format

Solid. Powder

Purity/Purification

98.00%

Preparation and Storage

Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent

Molecular Weight

601.86

Solubility

DMSO: 125mg/mL (207.69mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)

Formula

C36H59NO6

SMILES

O=C([C@]1(CC[C@H]2C(C)=C)[C@@]2([H])[C@](CC[C@@]3([H])[C@]4(CC[C@]5([H])[C@@]3(CC[C@H](OC(C)=O)C5(C)C)C)C)([H])[C@@]4(C)CC1)OCC(CO)(N)CO

CAS Number

745020-66-0

Target & IC50

Others

In Vitro

The intravenous application of NVX-207 is well tolerated in mice[1].

Product References and Citations for NVX-207, inhibitor

Willmann M, et al. Characterization of NVX-207, a novel betulinic acid-derived anti-cancer compound. Eur J Clin Invest. 2009 May;39(5):384-94.
Willmann M, et al. Characterization of NVX-207, a novel betulinic acid-derived anti-cancer compound. Eur J Clin Invest. 2009 May;39(5):384-94.
Bache M, et al. Betulinic acid derivatives NVX-207 and B10 for treatment,of glioblastoma--an in vitro study of cytotoxicity and radiosensitization. Int J Mol Sci. 2014 Oct 30;15(11):19777-90.
Bache M, et al. Betulinic acid derivatives NVX-207 and B10 for treatment,of glioblastoma--an in vitro study of cytotoxicity and radiosensitization. Int J Mol Sci. 2014 Oct 30;15(11):19777-90.

Other Notes

Small volumes of NVX-207, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

NVX-207 Inhibitor

Product Overview

Structure of NVX-207, inhibitor

Related Product Information for NVX-207, inhibitor

Product References and Citations for NVX-207, inhibitor

Other Notes